Australia markets closed

Cocrystal Pharma Inc (8CC.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.0600+0.1100 (+5.64%)
At close: 08:14PM CEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
2,014
-
Operating expenses
Research development
14,212
15,169
12,392
8,794
6,034
-
Selling general and administrative
5,994
5,990
5,745
5,427
5,566
-
Total operating expenses
20,206
21,159
18,137
14,221
11,600
-
Operating income or loss
-20,206
-21,159
-18,137
-14,221
-9,586
-
Interest expense
-
-
2
4
8
19
Total other income/expenses net
2,595
2,535
-20,698
40
-54
-
Income before tax
-16,751
-17,984
-38,837
-14,185
-9,648
-
Income tax expense
-
-
-
-
0
0
Income from continuing operations
-16,751
-17,984
-38,837
-14,185
-9,648
-
Net income
-16,751
-17,984
-38,837
-14,185
-9,648
-
Net income available to common shareholders
-16,751
-17,984
-38,837
-14,185
-9,648
-
Basic EPS
-1.97
-
-4.77
-0.16
-2.04
-18.12
Diluted EPS
-1.97
-
-4.77
-0.16
-2.04
-18.12
Basic average shares
9,132
-
8,143
7,364
4,601
2,655
Diluted average shares
9,132
-
8,143
7,364
4,601
2,655